PATENT CLAIM ANALYSIS

Application Number: 15893235
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-10
Patent Classification: ["514", "507000"]

Abstract:
The present invention provides methods for increasing plasma dUrd levels comprising the administration of 6R-MTHF. The methods of increasing plasma dUrd increase dUrd levels compared to equimolar concentrations of LV. The present invention also provides methods for increasing TS inhibition comprising the administration of 6R-MTHF. The present invention also provides methods for increasing TS inhibition comprising the administration of 6R-MTHF.

Claim (Index 4):
The method of  claim 1 , where the pharmaceutical composition is administered as a bolus.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 88.0
- Lexical Diversity: 2.56
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15865847', '15114690', '11586215', '15198769', '12464662']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7082355301281962
- 35 USC 102 Novelty (BERT): 0.5443218899957668
- Combined Prediction Score: 0.6918441661149533
- Mean Citation Score: 245.837854
- Max Citation Score: 402.69376
- Similarity Product: 251.454448910408

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test